Front Row Advisors’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-20,445
Closed -$957K 1059
2019
Q2
$957K Hold
20,445
0.7% 51
2019
Q1
$794K Buy
20,445
+1,370
+7% +$56.1K 0.62% 51
2018
Q4
$720K Sell
19,075
-75
-0.4% -$3.8K 0.63% 53
2018
Q3
$1K Buy
19,150
+130
+0.7% +$8.04K 0.7% 40
2018
Q2
$1.18K Buy
19,020
+405
+2% +$20.2K 0.75% 39
2018
Q1
$974K Buy
18,615
+1,640
+10% +$87.7K 0.68% 41
2017
Q4
$815K Buy
+16,975
New +$841K 0.65% 47

Other funds holding CBM

Front Row Advisors's CBM Position: Q3 2019 in Review

Front Row Advisors sold out of Cambrex Corporation (CBM) in Q3 2019, closing a stake of 20,445 shares — an estimated $957K sold.

Front Row Advisors first reported a position in CBM in Q4 2017 and held it in 7 quarters. The position peaked at $974K in Q1 2018. 201 funds tracked by Wall St. Rank hold CBM as of Q3 2019.

  • Front Row Advisors reported no remaining Cambrex Corporation position as of Q3 2019 after selling out during the quarter.
  • Front Row Advisors sold 20,445 Cambrex Corporation shares in Q3 2019, an estimated $957K.
  • Front Row Advisors first reported a position in Cambrex Corporation in Q4 2017 and held it in 7 quarters.
  • Front Row Advisors's Cambrex Corporation position peaked at $974K in Q1 2018.
  • 201 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2019.

Based on Front Row Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.